DEA Past Meetings & Events
- Home
- About Us
- Meetings & Events
- Past Meetings & Events
Past Meeting Reports and Presentations
Telemedicine Listening Sessions
On September 12 and 13, 2023, DEA hosted public listening sessions and received comments from 58 healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine.
The listening sessions were livestreamed with virtual participation available. A transcript of the listening sessions is forthcoming. All comments and presentations will become part of the official record for the purposes of rulemaking.
DEA Supply Chain Conference
May 2-4, 2023
The Westin Galleria Houston
The Drug Enforcement Administration (DEA), Diversion Control Division, hosted a Supply Chain Conference May 2-4, 2023, at the Westin Galleria Houston in Houston, Texas. This conference offered those registered with the DEA as Manufacturers, Distributors, Pharmacies, Importers or Exporters the opportunity to meet, share information and discuss concerns.
This was a three-day conference. Day 1 was for manufacturers and other registrants who need quota, and for all importers and exporters. Days 2 and 3 of the conference were geared toward regulatory compliance personnel for mid-level and senior managers.
Conference Report
Tuesday, May 2, 2023 (Day 1)
Quotas and Import/Export
International Drug Treaties and the CSA
Stacy Harper-Avilla, Section Chief, Quota and UN Reporting SectionThe 303 Process
Brenda Thomas, Program Analyst, Regulatory SectionQuotas – Aggregate Production Quotas, Individual Quotas, and Quota Applications
Mark Cunningham, Drug Science Specialist, Quota and UN Reporting SectionQuotas – Year End Reporting
Gregory Kavanagh, Drug Science Specialist, Quota and UN Reporting SectionResearch vs Manufacturing
Minh Dang, Drug Science Specialist, Quota and UN Reporting SectionImports and Exports of Controlled Substances and Listed Chemicals
Jacob Prieto, Acting Section Chief, Import/Export SectionPermit Applications/Declarations Process
Thomas Fahmy, Program Analyst, Import/Export SectionRe-Exports of Controlled Substances
Mark Via, Technical Information Specialist, Import/Export Section
Wednesday, May 3, 2023 (Day 2)
Registration
Holly Farrington, Program Analyst, Registration SectionCurrent Regulatory Priorities
Heather Achbach, Staff Coordinator, Regulatory, Drafting and Policy Support SectionARCOS Reporting
Sam Weisman, ARCOS Team Leader, Registration SectionChemicals
Stephanie Kolb, Staff Coordinator, Chemical Investigations SectionEmployment Waivers/Theft and Loss Reporting
Rostant Farfan, Staff Coordinator, Regulatory Section
Administrative Actions
Kerry Hamilton, Section Chief, Pharmaceutical Investigations
Thursday, May 4, 2023 (Day 3)
IT Transformation
Matthew Strait, Deputy Assistant Administrator, Diversion RegulatoryEmerging Trends
Terrance Boos, Section Chief, Drug and Chemical Evaluation SectionTableting & Encapsulating Machines LEADS Reporting
Stevie Ikner, Staff Coordinator, Import/Export SectionStimulants, Quotas, and Shortages – DEA and FDA
Matthew Strait, Deputy Assistant Administrator, Diversion Regulatory
Paras Patel, Manager, Global Pharmacovigilance and Risk Management
Food and Drug Administration
Practitioner Diversion Awareness Conference
February 22 & 23, 2020; Alexandria, Virginia
January 13 & 14, 2020; Albuquerque, New Mexico
December 16 & 17, 2019; Birmingham, Alabama
November 4 & 5, 2019; Columbia, Missouri
October 21 & 22, 2019; New Orleans, Louisiana
August 19 & 20, 2019; Manchester, New Hampshire
July 22 & 23, 2019; Indianapolis, Indiana
July 19 & 20, 2019; Phoenix, Arizona
June 14, 2019; Grand Rapids, Michigan
June 3 & 4, 2019; Dover, Delaware
May 5 & 6, 2019; Norman, Oklahoma
March 18-19, 2019; Cleveland, Ohio
February 4-5, 2019; Anaheim, California
December 17-18, 2018; Hershey, Pennsylvania
November 18-19, 2018; Nashville, Tennessee
November 9, 2018; Detroit, Michigan
September 29-30, 2018; Charleston, West Virginia
Researcher Training Conference
February 6, 2019; Hilton Anaheim – Anaheim, California
The Drug Enforcement Administration (DEA) held a training conference for all DEA registered Researchers in the State of California on Wednesday, February 6, 2019. There were two sessions conducted. The content of both sessions were exactly the same.
The diversion of pharmaceutical controlled substances throughout the United States is a growing problem. This diversion stems from various sources. This training assisted these registrants in identifying and preventing diversion activity by having a greater knowledge of Federal laws and regulations that affect these registrants. The DEA provided information regarding diversion, registration (including special requirements for schedule I researchers), campus registrations, security, required records and inventories, purchasing controlled substances (including compounded controlled substances), and disposal requirements.
Over 77 Researchers attended the training. Presentations included; Registration of Schedule I-V Researchers; Procedures for Campus Registration, Compounding Drug Issues and Destruction; and Records, Reports, Inventories, and Security.
Presentations from the Researcher Training Conference are below:
Registration of Schedule I-V Researchers – Loren T. Miller, Policy Section Chief, Diversion Control Division
Procedures for Campus Registration, Compounding Drug Issues and Destruction – Lynnette Wingert, Policy Unit Chief, Diversion Control Division
Records, Reports, Inventories, and Security – Charlotte D. Barron, Regulatory Section Chief, Diversion Control Division
NOTE: Presentations by private instructors do not constitute an endorsement by the DEA of the presenters or their products or services.